Dr O'Doherty: Clinical severity probably depends on the extent and location of the brain malformation and if this is slight it may not cause trouble in later life. Some symptoms, such as neonatal convulsions, might be only coincidental, especially where they are easily controlled by treatment.
Professor S Shuster: Can I press this question further? Up to what age do the central nervous system lesions progress ? In a child of, say, 6 months or 1 year with an apparently normal central nervous system, is the outlook good or may neural degeneration still occur?
Dr O'Doherty: Every child with incontinentia pigmenti should be shown as early as possible to a pvdiatric developmental neurologist.
Dr B C Tate: Can the disease first present at the age of 2 years ? Dr O'Doherty: I do not know the answer. The recognition of significant minor neonatal neurological dysfunction is a fairly recent achievement and it remains to be seen how many ofthe children with incontinentia pigmenti perform normally in a formal neurological examination when they are less than a month old.
Dr M Feiwel: Do the genetics of incontinentia pigmenti illustrate the Lyon hypothesis ?
Dr O'Doherty: Yes, I believe so. This would imply that the abnormal gene is on an X chromosome, which is active where there are skin lesions and inactive in the other areas. This is a further reason for looking at the chromosomes of apparent males with this disorder.
Cases
Lymphoma with Lipid Deposits Anne E Walker MD (for I B Sneddon MB FRCP) (Royal Infirmary, Sheffield) G M, man aged 64 History: In the summer of 1962 he developed a generalized erythroderma with exfoliative dermatitis. The exfoliation was controlled by prednisolone from July to March 1964. A further recurrence of the exfoliation was quickly relieved by triamcinolone 4 mg twice daily in December 1964 and this has been continued to the present time. The patient's hands and face have remained erythematous and irritable and this has been aggravated by sunlight. In November 1966 he developed infiltrated papules on the dorsum of both hands and at the same time the skin of his face was noted to be creamy in appearance.
Past history: 1945, scaly rash around the hair margin. 1947-52, scattered scaly lesions on the trunk and limbs which cleared without treatment.
Family history: No skin disease.
On examination: Confluent dusky erythema of the face and scalp, contrasting sharply with the creamy appearance of his forehead and nasolabial folds (Fig 1) . Hands cyanotic and studded with infiltrated papules on the dorsum and both aspects of the wrists. Warty keratoses cover the palms. Skin of trunk and limbs rather dry and scaly but normal in colour. Biopsies: An infiltrated papule from the hand shows a dense polymorphic infiltrate in the upper dermis consisting of reticulum cells, cells of the lymphocyte series and a few plasma cells. There is some pleomorphism in the reticulum cells and an occasional mitotic figure. The creamy area on the cheek shows a dense xanthomatous infiltrate in the upper dermis with a few Touton type giant cells. Deep to this is a focal infiltrate of histiocytes and lymphocytes. Lipid is also demonstrable in this area.
Comment
This is the third patient we have seen in Sheffield with this combination of lymphoma and lipid deposition. The first was a woman who, having had an exfoliative dermatitis for three years, then developed plaques typical of premycotic mycosis fungoides and similar lipid deposition in the skin of the face and neck. The second patient was a man with a long history of exfoliative dermatitis; lipid deposits and a lymphomatous infiltrate of the face appeared at the same time. In all three patients the serum cholesterol level was within the normal range. All had received systemic steroid therapy for their exfoliative dermatitis. No previous association between lipid deposition and lymphomata has been recorded. However, we feel that this is more likely to be related to the underlying lymphomatous process than to the steroid therapy.
Dr M Feiwel: There are various ways in which xanthomatous deposits arise. Thus they result from the primary hyperlipidemias and from those secondary to other disorders. Dysproteinmmias may produce lipoprotein abnormalities and reticulotic clones of cells at other sites can be responsible for cutaneous xanthomata, as in patients shown at this Section by Borrie (1958, Proc. R. Soc. Med. 51, 324), Marten (1962, Proc. R. Soc. Med. 55, 318) and McKenzie (1964, Proc. R. Soc. Med. 57, 889) . On the other hand, lymphoma cells in the skin itself could manufacture excess lipid, molecular biology offering an explanation for this. Again, glucocorticoids used in therapy, especially in combination with anabolic steroid, may cause a hyperlipid&mia.
Dr R J Cairns: The lipid deposits are peculiarly confined to the face and are unlike those occasionally associated with multiple myeloma; they are not xanthomatous clinically. There may be a similarity here with dermatopathic lymphadenopathy (lipomelanic reticulosis) where lipid from the skin is carried, along with melanin, to the regional lymph nodes. How and why such lipid arises in the skin is unknownit might conceivably be exogenic. A chemical analysis of the dermal deposit in this patient would be of interest.
Professor S Shuster: These cases are called lymphoma, but is this really a reticulosis? I have had several similar cases, although I did not know about the lipid.
Their histology was what Dr Wilson Jones might have called 'nasty', 'quite nasty' or even 'very nasty'. Nevertheless, their skin condition has ultimately regressed and I think this was just the long tail end of an exfoliative dermatitis.
The following cases were also shown:
( 
